- Cell and molecular biology
- Biomarkers
- Epidemiology, prevention and public health
- Experimental therapeutics and drug development
- Genetics, genomics and epigenetics
- Infection, immunity and cancer vaccines
- Medical and radiation oncology
- Surgical oncology, cancer imaging and interventional therapeutics
- Systems biology, post-genomic analysis and emerging technologies
- Supportive therapy, cancer burden and survivorship
New collection: Advances in CAR-T immunotherapy
Chimeric antigen receptor (CAR) T cells therapies, as a novel modality in cancer immunotherapy, provide a quantum leap in the treatment of cancer. BMC Cancer and BMC Biotechnology together present the latest collection of articles on the advances in CAR-T immunotherapy covering the entire range of advances from lab to clinic. Click on highlight to read the the full collection of articles.
Collection: Hepatitis C
The 2020 Nobel Prize for Physiology or Medicine was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of Hepatitis C virus. In celebration of what they started and showcasing areas of research that have since emerged, we here present a collection of articles from the BMC Biology, BMC Medicine, Genome Medicine and the BMC Series Journals on biology, diagnosis and treatment and wider public health and medical outcomes of the Hepatitis C virus and its infection.
Focus Issue Health Disparities
With World Humanitarian Day falling on 19th August, the BMC Series decided to focus on health disparities in August’s focus issue. Browse our biology, chemistry and medical titles for insight into health disparities, including racial health disparities, socioeconomic health disparities and regional disparities
Articles
-
-
14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
-
Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells
-
Artificial neural networks improve LDCT lung cancer screening: a comparative validation study
-
Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma
-
An electronic application for rapidly calculating Charlson comorbidity score
-
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
-
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression
-
Atypical glandular cells in conventional cervical smears: Incidence and follow-up
-
Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma
Featured review: Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico
Gallbladder cancer is a rare malignancy of the biliary tract with a poor prognosis, frequently presenting at an advanced stage. While rare in the United States overall, gallbladder cancer has an elevated incidence in geographically distinct locations of the globe including Chile, North India, Korea, Japan and the state of New Mexico in the United States. Rama R. Gullapalli, Associate Editor for BMC Cancer provides this review.
Featured video: Microparticles, breast cancer's secret weapon?
Your browser needs to have JavaScript enabled to view this video
Featured review: A stepwise approach to constructing systematic reviews
Systematic reviews, with or without meta-analysis, play an important role today in synthesizing cancer research and are frequently used to guide decision-making. With a focus on cancer, first author, Prof Kelley, provides a practical, stepwise approach for systematically reviewing the literature and publishing the results.
Featured article: Are cancer patients better off if they participate in clinical trials?
How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.
Aims and scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
Journal Sections
BMC Series Focus Issue
October: Animal Models
With World Animal Day falling on October 4th, the BMC series has decided to dedicate this month’s focus issue to animal models. Browse our titles for insight into recent research in the field, including growth regulation, lifespan variation, nephrotoxicity, cancer, lipid metabolism, autism, temperature-dependent development, drug resistance, inflammatory responses, disease resistance, sperm dynamics and antimicrobial residues in fish.
Trending BMC Cancer Articles
Click here to view which Articles have been shared most in the last 6 months!
Read our highly accessed articles
Editorial: Nobel Prize Cancer Immunotherapy!
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
BMC Series Blog
-
-
Getting real about kidney transplant timelines
08 October 2020
-
Highlights of the BMC Series: August 2020
18 September 2020
Follow
2019 Journal Metrics
-
Citation Impact
3.15 - 2-year Impact Factor
3.432 - 5-year Impact Factor
1.021 - Source Normalized Impact per Paper (SNIP)
1.186 - SCImago Journal Rank (SJR)Usage
4,151,734 downloads
Social Media Impact
3364 mentions
